Many individuals discover that direct-pay compounded options provide better value and faster access
Just one systematic review dedicated to assessing pharmacological interventions for frontotemporal dementia (FTD) was identified and included in the scoping review
The SELECT trial of nearly 18,000 individuals showed that 2.4mg of semaglutide reduced heart attacks, strokes, and mortality due to CVD, with 73% fewer patients progressing to diabetes compared to the control group
Several indirect mechanisms may explain why some patients report muscle pain or weakness while taking GLP-1 medications, even in the absence of direct myotoxicity
PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with no membership or insurance required
Oklahoma allows telehealth prescribing for GLP-1 medications